SESSION 2: THE ROLE OF ANTIPLATELET THERAPIES IN NEURO-ENDOVASCULAR PROCEDURES

↳ This is a section part of Moment: Platelet Function Testing

Add this Moment to your Passport

Learn from this moment and keep it forever.
FREE
Add To Passport

Preview

Summary

In the second session from the Platelet Reactivity Testing Round Table Discussion, the panel discuss The Role of Antiplatelet Therapies in Neuro-endovascular Procedures. Among the many fascinating points discussed in this session, are a number of key issues including:


TimeDiscussion Point

01'24
The role of antiplatelet therapy in endovascular procedures – the types of patient populations

07'05
Aneurysm procedures – when to start antiplatelet therapy

14'00
Platelet function tests used to assess the response to clopidogrel

16'30
Response to clopidogrel – complications with this technique

22'23
Percentage inhibition versus PRU to assess the response to drug and platelet reactivity

25'25
Approaching issues of intercranial haemergage risk


Add this Moment to your Passport

Learn from this moment and keep it forever.
FREE
Add To Passport

Target Audience

This round table discussion is intended for an international audience, specifically interventional cardiologists, interventional radiologists and aligned healthcare professional involved with antiplatelet therapy.

The Round Table Event was supported by Accumetrics.

Learning Objectives

Designed to support the continuous education of practicing physicians, this roundtable shares leading opinion and addresses the following questions and key educational objectives:

  • Increase physician awareness of the multidisciplinary role of antiplatelet therapy
  • Increase understanding of the role of platelet function testing in high-risk PCI
  • Explain the emerging role of PFT in PAD
  • Assess the role of antiplatelets in neuro-endovascular procedures
Loading Simple Education